Evidence map›Paper›PMID 38170001›Full record

ArticleCase reports in oncological medicine2023

A Rare Case of Nasal Sarcoma with BCOR Internal Tandem Duplication Showing Complete Pathologic Response to the VDC-IE Chemotherapy Protocol.

Samer Salah, Maher A Sughayer, Omar Jaber, Nebras Abu Abed, Fatena Ajlouni, Wisam Al Gargaz, Ramiz Abu Hijlih, Fawzi Abuhijla, Akram Al-Ibraheem, Farah Alul and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in oncological medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Samer SalahDepartment of Medical Oncology, King Hussein Cancer Center, Amman, Jordan.ORCID https://orcid.org/0000-0001-7421-2522
Maher A SughayerDepartment of Pathology, King Hussein Cancer Center, Amman, Jordan.ORCID https://orcid.org/0000-0002-9185-9616
Omar JaberDepartment of Pathology, King Hussein Cancer Center, Amman, Jordan.ORCID https://orcid.org/0000-0002-7207-8806
Nebras Abu AbedDepartment of Medical Oncology, King Hussein Cancer Center, Amman, Jordan.
Fatena AjlouniDepartment of Radiology, King Hussein Cancer Center, Amman, Jordan.
Wisam Al GargazDepartment of Surgery, King Hussein Cancer Center, Amman, Jordan.
Ramiz Abu HijlihDepartment of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.ORCID https://orcid.org/0000-0001-5397-6267
Fawzi AbuhijlaDepartment of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
Akram Al-IbraheemDepartment of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan.
Farah AlulDepartment of Cell Therapy and Applied Genomics, King Hussein Cancer Center, Amman, Jordan.
Walid NaserDepartment of Cell Therapy and Applied Genomics, King Hussein Cancer Center, Amman, Jordan.
King Hussein Cancer Center · JOJordan University of Science and Technology · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcoma with

Identifiers

PMID38170001
PMCPMC10761225
OpenAlexW4390224658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.